The first of four bellwether trials in the Xarelto® (rivaroxaban) multidistrict litigation in Louisiana Federal Court is currently underway. Plaintiff Joseph Boudreaux, 74, of Lockport, La., alleges that he developed gastrointestinal bleeding after he began taking Xarelto in 2014, requiring hospitalization, numerous blood transfusions and other serious treatments. As previously reported in this blog, this litigation...
Lawsuits have been and continue to be filed by individuals who have suffered various bleed-related injuries (often irreversible and fatal) as a result of taking Eliquis (apixaban), an oral tablet used to reduce the risk of stroke and dangerous blood clots (systemic embolism). Eliquis is manufactured by Bristol-Myers Squibb Company of Princeton, N.J. and marketed...
On September 21, 2016, U.S. District Court Judge Eldon E. Fallon reset the initial bellwether trial dates in the Xarelto® (rivaroxaban) multidistrict litigation due to the NBA All-Star game and related logistical issues it would create. As previously reported in this blog, this litigation involves hundreds of lawsuits from across the country alleging that individuals...
Copyright ©2024 Borgess Law
Law Firm Web Design by Black Fin